ArticleThe Journal of clinical investigation2016

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition.

Leonid Cherkassky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.